Investing Profile

Gregory Harriman

InvestorVCAngel
Partner, Chief Investment Officer at BioAdvance
Photo of Gregory Harriman, Partner at BioAdvance

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of California, Berkeley Network
261 CONNECTIONS
Johnson & Johnson Network
17 CONNECTIONS
cb
BioAdvance Partner
$1.5M - $5.0M
$3.3M
Venture Partner BioAdvance2012 - 2021
Director RIBONOVA INC.2016 - 2021
Director Genome Profiling, LLC2017 - 2018
Member Robin Hood Ventures2010 - 2017
Director Immunome2012 - 2017
Director Enzium, Inc.2015 - 2017
Director QR Pharma2012 - 2014
Research Professor, School of Biomedical Engineering, Science and Health Systems Drexel University2010 - 2014
Director Novira Therapeutics2011 - 2012
Vice President Johnson & Johnson2001 - 2009
Executive Director Centocor1998 - 2001
Medical Director IVAX1996 - 1998
Assistant Professor of Medicine Baylor College of Medicine1991 - 1996
Director Senzo Health2022 - Present
Partner, Chief Investment Officer BioAdvance2021 - Present
Director Opsidio, LLC2017 - Present
Director Treventis2012 - Present
President Main Line Ventures2006 - Present
UC San Diego School of Medicine M.D. Medicine
University of California, Berkeley